Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
HYNR-CS-Allo by Corestemchemon for Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration): Likelihood of Approval
HYNR-CS-Allo is under clinical development by Corestemchemon and currently in Phase I for Multiple System Atrophy (MSA or Shy-Drager Syndrome...
HYNR-CS-Allo by Corestemchemon for Spinocerebellar Ataxia (SCA): Likelihood of Approval
HYNR-CS-Allo is under clinical development by Corestemchemon and currently in Phase I for Spinocerebellar Ataxia (SCA). According to GlobalData, Phase...
HYNR-CS-Allo by Corestemchemon for Cerebellar Ataxia: Likelihood of Approval
HYNR-CS-Allo is under clinical development by Corestemchemon and currently in Phase I for Cerebellar Ataxia. According to GlobalData, Phase I...